Nilotinib in Parkinson's Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Parkinson Disease

In brief

This study will assess the safety and tolerability of daily oral administration of nilotinib (150-300mg once daily) in Parkinson's Disease.

Key facts

Study ID

NCT03205488

Run by

Northwestern University

People needed

76

Starts

2017-10-16

Expected to finish

2019-09-28

Last updated by the study team

2020-07-22

Who can join

Age: 40 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Barrow Neurological Institute — Sun City, Arizona, United States
• University of California Davis — Sacramento, California, United States
• University of Colorado at Denver — Aurora, Colorado, United States
• University of Florida — Gainesville, Florida, United States
• University of South Florida — Tampa, Florida, United States
• Rush University Medical Center — Chicago, Illinois, United States
• John Hopkins University — Baltimore, Maryland, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Michigan State University — East Lansing, Michigan, United States
• Cleveland Clinic - Las Vegas — Las Vegas, Nevada, United States
• Albany Medical College — Albany, New York, United States
• Beth Israel Medical Center — New York, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States
• University of Cincinnati — Cincinnati, Ohio, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Oregon Health and Science University — Portland, Oregon, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Baylor College of Medicine — Houston, Texas, United States
• University of Virginia — Charlottesville, Virginia, United States
• Inland Northwest Research — Spokane, Washington, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.